(1)
Neuhaus, T.; Luyken, J.; Stier, S. Discontinuation of the Tyrosine Kinase Inhibitor Sunitinib in Patients With Metastatic Renal Cell Carcinoma: A Case Series. Urol J 2014, 11, 1494-1498.